Results 111 to 120 of about 976,374 (357)

Liver Hypertrophy after Portal Vein Embolization with N-butyl-cyanoacrylate or Microparticles - A Retrospective Swedish Multicenter Study [PDF]

open access: bronze, 2023
Dennis Björk   +7 more
openalex   +1 more source

Mechanistic insights of rapid liver regeneration after associating liver partition and portal vein ligation for stage hepatectomy

open access: yesWorld Journal of Gastroenterology, 2016
AIM To highlight the potential mechanisms of regeneration in the Associating Liver Partition and Portal vein ligation for Stage hepatectomy models (clinical and experimental) that could unlock the myth behind the extraordinary capability of the liver for
D. Moris   +6 more
semanticscholar   +1 more source

A Dynamic DNA Nano‐Antioxidant Targeting Galectin‐3 Attenuates Liver Fibrosis via Reducing Macrophage Oxidative Stress

open access: yesAdvanced Science, EarlyView.
This study developed a dynamic DNA nano‐antioxidant (DDN) for Galectin‐3 siRNA delivery, specifically targeting hepatic macrophages to suppress ROS‐driven fibrosis. DDN enhanced hepatic accumulation, restored NRF2 signaling, and attenuated oxidative stress, collagen deposition, and fibrotic progression in a CCl4‐induced cirrhosis model, demonstrating ...
Mengjia Peng   +6 more
wiley   +1 more source

Down-regulation of metabolic proteins in hepatocellular carcinoma with portal vein thrombosis

open access: yesClinical Proteomics, 2017
Background Hepatocellular carcinoma is an aggressive malignancy with poor prognosis and easy to recur even the tumor is totally removed by surgery. Portal vascular invasion is one of the major factors contributing to tumor recurrence and poor prognosis ...
Wei-Chen Lee   +7 more
doaj   +1 more source

Control of severe portal bleeding by carrier-bound fibrin sealant [PDF]

open access: yes, 2018
Bleeding during liver surgery and liver transplantation (LT) can be caused by coagulation disorders, portal vein hypertension, and adhesions from previous surgical procedures.
Apestegui, Carlos   +3 more
core  

Current knowledge and management of portal vein thrombosis in cirrhosis.

open access: yesJournal of Hepatology, 2021
M. Senzolo   +2 more
semanticscholar   +1 more source

Seipin‐Mediated Lipid Droplet Formation in Cardiomyocytes Ameliorates Cardiac Ischemia/Reperfusion Injury

open access: yesAdvanced Science, EarlyView.
Lipid droplets (LDs) protect the heart against lipotoxicity in cardiac ischemia/reperfusion (I/R) injury; however, they are insufficient to prevent cardiomyocyte death. Seipin plays a central role in the insufficient formation of LDs, subsequent lipotoxicity, and myocardial injury during cardiac I/R injury.
Changyun Liu   +13 more
wiley   +1 more source

Use of Left Gastric Vein as an Alternative for Portal Flow Reconstruction in Liver Transplantation

open access: yesCase Reports in Surgery, 2016
Portal vein thrombosis is observed in up to 10% of liver transplant candidates, hindering execution of the procedure. A dilated gastric vein is an alternative to portal vein reconstruction and decompression of splanchnic bed.
Uirá Fernandes Teixeira   +12 more
doaj   +1 more source

Portal venous tumor growth-type of hepatocellular carcinoma without liver parenchyma tumor nodules: a case report

open access: yesAnnals of Hepatology, 2013
The patient was a 43-year-old man with chronic hepatitis B without history of hepatocellular carcinoma (HCC), who was first diagnosed with thrombosis in right portal vein trunk and portal vein branches and ruptured esophageal varices in October 2011.
Masaya Saito   +9 more
doaj   +1 more source

Living Donor Liver Transplantation to a Survivor of LiverResection for Hepatocellular Carcinoma with Major Portal Vein Invasion [PDF]

open access: yes, 2013
We present a case of living donor liver transplantation to a 3-year disease-free survivor of liver resection for hepatocellular carcinoma (HCC) with major portal vein invasion.
Fujiwara, Toshiyoshi   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy